Go back to European Union page
forproviders forpolicymakers
Primary purpose: To assist healthcare professionals in managing cardiovascular health in oncology patients by providing guidance on the prevention, diagnosis, treatment, and monitoring of cancer therapy-related cardiovascular toxicity.
Sponsor, manager or home institution: European Society of Cardiology (ESC).
Type of information: Recommendations about screening, diagnosis, medical procedures, cancer survival information, comorbidities, risk of cancer, primary tumour localization. Click here to learn more.
Cancer Areas of Interest: C00-D48: All neoplasms. Click here to learn more.
Access to information: Click here to access.
Mouth
Throat
Oropharynx
Nasopharynx
Hypopharynx
Larynx
Salivary glands
Lips
Tonsils
base of tongue
Voice box
Esophagus
Stomach
Small intestine
Large intestine
Colon
Rectum
Anus
Liver
Gallbladder
Bile ducts
Pancreas
Lung
Trachea
Bronchi
Pleura
Mediastinum
Bone
Cartilage
Osteosarcoma
Ewings sarcoma
Skin
Melanoma
Scalp
Lips
Hands
Feet
Muscle
Fat
Tendon
Ligament
Blood vessels
Connective tissue
Sarcoma
Angiosarcoma
Liposarcoma
Lobular
Breast
Nipple
Areola
Ductal
Vulva
Vagina
Cervix
Uterus
Ovary
Fallopian tubes
Endometrium
Prostate
Testicles
Penis
Kidney
Ureter
Bladder
Urethra
Eye
Brain
Spinal cord
Thyroid gland
Parathyroid
Adrenal glands
Pituitary gland
Pancreas
Thymus gland
Peritoneum
Pericardium
Retroperitoneum
Mesothelium
Blood
Bone marrow
Lymph nodes
Spleen
Leukemia
dataOwner::European Society of Cardiology (ESC)
availableVariable::screening
availableVariable::diagnosis
availableVariable::medical procedures
availableVariable::cancer survival
availableVariable::comorbidities
availableVariable::risk of cancer
availableVariable::primary tumour localization
hasCancerType::C00-D48: All neoplasms
